This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Kuno Wuersch: Innovator in Cancer Treatment
Introduction
Kuno Wuersch is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work focuses on the combination of specific inhibitors and therapeutic agents to enhance treatment efficacy.
Latest Patents
Kuno Wuersch holds a patent for "Combinations of FGFR4 inhibitors and bile acid sequestrants." This invention relates to a pharmaceutical combination that includes an FGFR4 inhibitor and a bile acid sequestrant. The patent outlines the use of this combination in treating cancer and highlights the role of bile acid sequestrants in reducing side effects associated with FGFR4 inhibition therapy.
Career Highlights
Kuno Wuersch is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in the pharmaceutical industry. His research and development efforts have contributed to advancements in cancer therapies.
Collaborations
Kuno has collaborated with notable colleagues, including Robin Alec Fairhurst and Diana Graus Porta. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical sector.
Conclusion
Kuno Wuersch's contributions to cancer treatment through his patented inventions demonstrate his commitment to advancing medical science. His work continues to impact the pharmaceutical industry positively.